Reaction
Complications Of Bone Marrow Transplant reporting signals
As of the last recalculation, Complications Of Bone Marrow Transplant appears in 361 FAERS reports alongside 17 co-occurring drug terms. The strongest observed disproportionality signal is BUSULFAN (PRR 193.0).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Busulfan | 46 | 193.0 | 193.6 |
| Anti-Thymocyte Globulin (Rabbit) | 12 | 88.7 | 88.8 |
| Thiotepa | 14 | 87.9 | 88.0 |
| Anakinra | 21 | 77.4 | 77.5 |
| Mesna Injection | 8 | 57.1 | 57.1 |
| Mesna | 8 | 56.0 | 56.1 |
| Thalidomide | 32 | 55.0 | 55.1 |
| Melphalan Hydrochloride | 22 | 53.8 | 53.9 |
| Fludarabine Phosphate | 31 | 49.6 | 49.7 |
| Melphalan | 18 | 48.0 | 48.0 |
| Deferasirox | 19 | 43.6 | 43.6 |
| Cyclophosphamide Injection, Solution | 83 | 34.8 | 34.8 |
| Cyclophosphamide | 83 | 34.8 | 34.8 |
| Cyclophosphamide For Injection | 83 | 34.8 | 34.8 |
| Etoposide | 35 | 30.3 | 30.3 |
| Brentuximab Vedotin | 4 | 22.7 | 22.8 |
| Blinatumomab | 4 | 22.3 | 22.3 |